scholarly article | Q13442814 |
P2093 | author name string | S. Goldfarb | |
C. Waltenbaugh | |||
B. Jubelt | |||
R. P. Oates | |||
S. L. Ropka | |||
P2860 | cites work | The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity, and disappearance | Q28235201 |
Some Contributions of the HL-A Complex to the Genetics of Human Diseases | Q33465540 | ||
A twin-family study of susceptibility to poliomyelitis | Q35251432 | ||
Characterization and myocarditic capabilities of coxsackievirus B3 variants in selected mouse strains | Q36895904 | ||
Lack of neutralizing antibodies to caprine arthritis-encephalitis lentivirus in persistently infected goats can be overcome by immunization with inactivated Mycobacterium tuberculosis | Q36911729 | ||
Quantitation of enterovirus 70 antibody by microneutralization test and comparison with standard neutralization, hemagglutination inhibition, and complement fixation tests with different virus strains | Q38479627 | ||
Genetically controlled resistance to virus infections of the central nervous system | Q39503190 | ||
HLA-A, -B, and -D Antigens in Paralytic Poliomyelitis | Q39556365 | ||
Immunosuppression: a means to assess the role of the immune response in acute virus infections | Q40015629 | ||
African swine fever: a reassessment. | Q40323239 | ||
Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. II. Survey of host immune responses and central nervous system virus titers in inbred mouse strains | Q41337544 | ||
Demyelination induced by Theiler's virus: influence of the H-2 haplotype | Q41362044 | ||
Study of the HLA antigen in Arab children with paralytic poliomyelitis | Q41449906 | ||
Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TEMV-specific delayed-type hypersensitivity | Q41489563 | ||
Differential resistance to paralytic poliomyelitis controlled by histocompatibility leukocyte antigens | Q42668895 | ||
Pathogenesis of human poliovirus infection in mice. II. Age-dependency of paralysis. | Q44010294 | ||
Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients | Q44255828 | ||
Cell-mediated immune responses to poliovirus II. Survey of delayed hypersensitivity and T-cell proliferative responses in inbred mouse strains | Q44807444 | ||
Coxsackievirus B3 murine myocarditis: wide pathologic spectrum in genetically defined inbred strains | Q45007013 | ||
Genetic analysis of susceptibility to Theiler's virus-induced demyelinating disease in mice. | Q45794739 | ||
The intercellular gaps of the neuropil as possible pathways for virus spread in viral encephalomyelitides | Q45811244 | ||
An Association of HL-A3 and HL-A7 with Paralytic Poliomyelitis | Q47857933 | ||
The distribution within the brain of ferritin injected into cerebrospinal fluid compartments. II. Parenchymal distribution. | Q51248292 | ||
Abortive poliomyelitis or minor illness as a clue to genetic susceptibility | Q67420977 | ||
Cell-mediated immune responses to poliovirus. I. Conditions for induction, characterization of effector cells, and cross-reactivity between serotypes for delayed hypersensitivity and T cell proliferative responses | Q69337691 | ||
Anti-thymocyte serum delays clearance of poliovirus from the mouse central nervous system | Q69338011 | ||
Variations in the susceptibility to Coxsackievirus B3-induced myocarditis among different strains of mice | Q70128440 | ||
Lansing poliovirus infection in mice: antibody demonstrable by enzyme-linked immunosorbent assay (ELISA) and immunoprecipitation but not by neutralization | Q70161761 | ||
Poliovirus infection of cyclophosphamide- treated mice results in persistence and late paralysis: I. Clinical, pathologic, and immunologic studies | Q70193407 | ||
Poliovirus infection of cyclophosphamide-treated mice results in persistence and late paralysis: II. Virologic studies | Q70193410 | ||
Pathogenesis of human poliovirus infection in mice. I. Clinical and pathological studies | Q72850426 | ||
Prolonged intracerebral infection with poliovirus in asymptomatic mice | Q72901003 | ||
Paralytic consequences of poliomyelitis infection in different parts of the world and in different population groups | Q75878252 | ||
An outbreak of poliomyelitis in Canadian Eskimos in wintertime | Q80615011 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | immunology | Q101929 |
microbiology | Q7193 | ||
Poliovirus | Q70923324 | ||
P304 | page(s) | 1035-40 | |
P577 | publication date | 1991-02-01 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Susceptibility and resistance to poliovirus-induced paralysis of inbred mouse strains | |
P478 | volume | 65 |
Q36650977 | A mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice. |
Q34316914 | Characterization of three different transgenic mouse lines that carry human poliovirus receptor gene--influence of the transgene expression on pathogenesis. |
Q35845137 | Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine |
Q27469670 | Differences between C57BL/6 and BALB/cBy mice in mortality and virus replication after intranasal infection with neuroadapted Sindbis virus |
Q45878942 | Genetic characterization of sabin types 1 and 3 poliovaccine virus following serial passage in the human intestinal tract |
Q48746513 | Non-invasive imaging of mouse hepatitis coronavirus infection reveals determinants of viral replication and spread in vivo. |
Q33918627 | Poliomyelitis in transgenic mice expressing CD155 under the control of the Tage4 promoter after oral and parenteral poliovirus inoculation |